Hysbysiad addasu
Modification of a contract/concession during its term
Adran I:
Endid
contractio
I.1) Enw a chyfeiriad
Betsi Cadwaladr University Health Board
Headquarters, Ysbyty Gwynedd, Penrhosgarnedd
Bangor
LL57 2PW
UK
Person cyswllt: Vicky Allum
Ffôn: +44 2921501263
E-bost: vicky.allum@wales.nhs.uk
NUTS: UKL
Cyfeiriad(au) rhyngrwyd
Prif gyfeiriad: https://bcuhb.nhs.wales/
Cyfeiriad proffil y prynwr: https://www.sell2wales.gov.wales/search/Search_AuthProfile.aspx?ID=AA88547
Adran II: Gwrthrych
II.1) Cwmpas y caffaeliad
II.1.1) Teitl
Edoxaban Review Service W91029
Cyfeirnod: BCU-MSP02-Edoxaban-W91029
II.1.2) Prif god CPV
85121100
II.1.3) Y math o gontract
Gwasanaethau
II.2) Disgrifiad
II.2.2) Cod(au) CPV ychwanegol
85121100
II.2.3) Man cyflawni
Cod NUTS:
UKL
UKL23
II.2.4) Disgrifiad o’r caffaeliad
Edoxaban Review Service is a service that requires a clinical review of all patients prescribed edoxaban for atrial fibrillation registered with GPs in BCUHB to assess if they are suitable for a more cost effective alternative and then change those that are.
Part 1 - Edoxaban Patient Review
Clinical review of the records of patients prescribed edoxaban.
Those deemed suitable for a switch proceed to a consultation with the patient or their representative. Consultations to switch edoxaban to generic apixaban or generic rivaroxaban can be done via telephone, virtually or face-to-face.
Part 2 - Edoxaban Patient Review that results in a switch to generic apixaban or generic rivaroxaban
If clinically appropriate and the patient agrees to the switch to either generic rivaroxaban or generic apixaban; prescribe as indicated.
Provider is Bodowen Surgery, Halkyn Road, Holywell, CH8 7GA
II.2.7) Hyd y contract, y cytundeb fframwaith, y system brynu ddynamig neu’r consesiwn
Dechrau:
03/08/2026
Diwedd:
31/01/2027
II.2.13) Gwybodaeth am Gronfeydd yr Undeb Ewropeaidd
Mae'r broses gaffael yn gysylltiedig â phrosiect a/neu raglen a ariennir gan gronfeydd yr Undeb Ewropeaidd:
Na
Section IV: Gweithdrefn
IV.2) Gwybodaeth weinyddol
IV.2.1) Cyhoeddiad blaenorol mewn perthynas â’r weithdrefn hon
Rhif yr hysbysiad yn OJ S:
2026/S 000-071862
Section V: Dyfarnu contract/consesiwn
Rhif Contract: BCU-MSP02-Edoxaban-W91029
Teitl: Edoxaban Review Service W91029
V.2 Dyfarnu contract/consesiwn
V.2.1) Y dyddiad y daeth y contract i ben/consesiwn
04/08/2026
V.2.2) Gwybodaeth am dendrau
Dyfarnwyd y contract i gr?p o weithredwyr economaidd:
Na
V.2.3) Enw a chyfeiriad y contractwr/consesiynydd
Bodowen Surgery
Halkyn Road
Holywell
CH8 7GA
UK
Ffôn: +44 1352363061
NUTS: UKL23
BBaCh yw’r contractwr/consesiynydd:
Ydy
V.2.4) Gwybodaeth am werth y contract/lot /consesiwn (heb gynnwys VAT)
Cyfanswm gwerth y contract/lot/consesiwn: 2 160.00 GBP
Section VI: Gwybodaeth ategol
VI.3) Gwybodaeth ychwanegol
This is a Provider Selection Regime Wales (PSR Wales) confirmation of contract award notice. The awarding of this contract is subject to the Health Services (Provider Selection Regime) (Wales) Regulations 2025. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015/Procurement Act 2023 do not apply to this award. The publication of this notice marks the award to a provider under the Most Suitable Provider Process, this notice serves as an award of contract under the PSR Wales.
Contract awarded is Edoxaban Review Service 3rd August 2026 to 31st January 2027.
The decision makers were the Associate Director Primary Care, Medical Director Primary Care, Head of Pharmacy Primary Care, Primary Care Contracts Manager and Clinical Governance Managers. There are no noted conflict of interests. No providers were excluded.
(WA Ref:169502)
VI.4) Gweithdrefnau adolygu
VI.4.1) Corff adolygu
High Court
Royal Courts of Justice, The Strand
London
WC2A 2LL
UK
Ffôn: +44 2079477501
VI.5) Dyddiad anfon yr hysbysiad hwn
21/08/2026
Section VII: Addasiadau i’w contract/consesiwn
VII.1) Disgrifiad o’r caffaeliad ar ôl yr addasiadau
VII.1.1) Prif god CPV
85121100
VII.1.2) Cod(au) CPV ychwanegol
VII.1.3) Man cyflawni
Cod NUTS:
UKL23
VII.1.4) Disgrifiad o’r caffaeliad
Most Suitable Provider Process confirmation of contract award notice, for the avoidance of doubt, this notice does not represent a modification of contract.
VII.1.5) Hyd y contract, y cytundeb fframwaith, y system brynu ddynamig neu’r consesiwn
Dechrau:
03/08/2026
Diwedd:
31/01/2027
VII.1.6) Gwybodaeth am werth y contract/lot/consesiwn (heb gynnwys TAW)
Cyfanswm gwerth y caffaeliad: GBP
Dyfarnwyd y contract/consesiwn i gr?p o weithredwyr economaidd:
Na
VII.1.7) Enw a chyfeiriad y contractwr/consesiynydd
Bodowen Surgery
Halkyn Road
Holywell
CH8 7GA
UK
Ffôn: +44 1352363061
NUTS: UKL23
BBaCh yw’r contractwr/consesiynydd:
Ydy
VII.2) Gwybodaeth am addasiadau
VII.2.1) Disgrifiad o’r addasiadau
This is a Provider Selection Regime Wales (PSR Wales) confirmation of contract award notice. This contract has been awarded under the Health Services (Provider Selection Regime) (Wales) Regulations 2025. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015/Procurement Act 2023 do not apply to this award. This contract has now been formally awarded using the Most Suitable Provider Process.
VII.2.2) Rhesymau dros addasu
Angen gwaith, gwasanaethau neu gyflenwadau ychwanegol gan y contractwr/consesiynydd gwreiddiol
Disgrifiad o’r rhesymau economaidd neu dechnegol a’r anghyfleuster neu’r achos o ddyblygu costau sy’n atal newid contractwr:
Most Suitable Provider Process confirmation of contract award notice, for the avoidance of doubt, this notice does not represent a modification of contract.
VII.2.3) Cynnydd mewn pris
Cyfanswm gwerth y contract wedi’i ddiweddaru cyn yr addasiadau (gan ystyried addasiadau cynharach posibl i’r contract ac i brisiau ac, yn achos Cyfarwyddeb 2014/23/EU, chwyddiant cyfartalog yn yr Aelod-wladwriaeth dan sylw)
Gwerth heb gynnwys TAW: 2 160.00 Arian cyfred: GBP
Cyfanswm gwerth y contract ar ôl yr addasiadau
Gwerth heb gynnwys TAW: 2 160.00 Arian cyfred: GBP